Top Drug Discovery Companies

Develops Hypercon hyper-concentrated microparticle formulations to enable subcutaneous delivery o...

Clinical-stage precision medicine oncology company developing targeted therapeutics using molecul...

Computational drug discovery company designing small-molecule correctors for diseases caused by p...

Develops therapeutics that restore mitochondrial function for rare and common diseases using geno...

AI-driven biotech developing next-generation menin inhibitors and small-molecule therapeutics for...

Monte Rosa Therapeutics is a biotechnology company developing molecular glues to degrade disease-...

Biotechnology company developing oral small-molecule ‘molecular gates’ to eliminate disease-causi...

Staccato

Biotechnology company dedicated to developing immune reset therapeutics for people living with ch...

AI-enabled drug discovery company using machine learning and knowledge graphs to identify novel d...

AI-enabled biotech using generative AI to discover and develop treatments for rare diseases, adva...

Therapeutics company pioneering small molecule drug discovery by engineering biology and chemistr...

Clinical-stage biotech developing selective oral NSD2/MMSET inhibitors for multiple myeloma and p...

Harvard-Deerfield joint translational life science R&D company advancing university innovations t...

Preclinical-stage biotech developing next-generation oncolytic virus therapies for solid tumors.

PillPack is an online pharmacy that simplifies medication management by pre-sorting and deliverin...

Orbis Medicines is pioneering a new era for oral macrocycle drug discovery.

Develops MicroOrganoSphere ex vivo tumor models and AI analytics to guide precision oncology and ...

Software therapy deployment platform simplifying prescription management, delivery, and patient a...

Accurate single-molecule quantification of proteins and proteoforms

Platform therapeutics company building an AI-guided in vivo drug discovery engine for tissue-targ...

Biotech developing antibody-based KnotBody therapeutics targeting ion channels and GPCRs to treat...

Oral pharmacological chaperone protein therapies to address diseases that result from protein mis...

A clinical-stage oncology company advancing small molecules that combine both targeted and immune...

Personalized drug discovery for blood cancer.